8 December 2015 - Sandoz announced today that the EMA has accepted their Marketing Authorization Application for a biosimilar to Pfizer's EU-licensed Enbrel (etanercept).

For more details, go to: https://www.novartis.com/news/media-releases/sandoz-advances-its-biosimilars-program-european-medicines-agency-ema-acceptance